In contrast, the percentage of eGFP+ HMC3 decreased only slightly during Tha-eGFP (25.4 to 19.8%, adjusted p-value > 0.0083) and Th2P-4M-eGFP infection (from 21.8 to 14.5%, adjusted p-value > 0.0083) upon IFN-α treatment compared to non-treated HMC3 (Figure S2). Here, IFNA1 is linked to infection.